EUROPEAN MARKETS FOR PERIPHERAL VASCULAR STENTS

151 Pages | 41 Exhibits | 2011 Analysis | Forecasts Through 2014

OVERVIEW:
First introduced in the early 1990s as a bailout technique for suboptimal or failed iliac angioplasty, peripheral vascular stenting gradually emerged as a valuable and versatile tool for a variety of primary and adjuvant applications within noncoronary vasculature. In 2010, peripheral vascular stents were used in more than 148,300 interventional procedures (including iliac artery stenting, fem-pop stenting, TIPS procedures, renal artery stenting, endovascular AAA repair, and carotid artery stenting) in the European countries covered by this report (France, Germany, Italy, Spain, and the United Kingdom) generating an estimated $437 million in corresponding product sales. Over the forecast period covered by this report, the number of peripheral vascular stenting procedures performed in Europe is expected to increase at 5% growth rate, reaching nearly 181,200 in the year 2014; during the same period, corresponding dollar sales are expected to increase at a 9% growth rate, reaching approximately $619 million in the year 2014.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European peripheral vascular stents market. Major topics covered by this report include a discussion of current and emerging peripheral vascular stenting technologies; a clinical overview of peripheral vascular conditions targeted by stenting, and an analysis of the European markets for iliac artery stents, fem-pop stents, TIPS devices, renal artery stents, AAA repair stent-grafts, and carotid artery stents.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Stent Design 
ii. Procedure Volumes 
iii. Market Analysis 
	a. Iliac Artery Stents 
	b. Femoropopliteal Stents 
	c. Transjugular Intrahepatic Portosystemic Shunts 
	d. Renal Artery Stents 
	e. Endovascular Abdominal Aortic Aneurysm Repair Stent-Grafts 
	f. Carotid Artery Stents 

Exhibit ES-1: Europe, Peripheral Vascular Stenting, Combined Procedure Volumes Forecast, 2010-2014 
Exhibit ES-2: Europe, Peripheral Vascular Stents, Combined Market Forecast, 2010-2014 

1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES

1.1 Stent Design 
	1.1.1 Vascular Stents 
	1.1.2 Nonvascular Stents 
	1.1.3 Stent Deployment Mechanisms 
1.2 Stent Materials 
	1.2.1 Metal Stents 
		1.2.1.1 Absorbable Magnesium Alloys 
		1.2.1.2 Cobalt Alloys 
		1.2.1.3 Nickel-Titanium Alloys 
		1.2.1.4 Stainless Steel 
	1.2.2 Standard Polymeric Stents 
	1.2.3 Biodegradable Polymeric Stents 
1.3 Stent Coatings 
	1.3.1 Radiopacity Enhancement 
	1.3.2 Biocompatibility Enhancement 
	1.3.3 Active Therapeutic Enhancement 
		1.3.3.1 Drug-Eluting Stents 
			1.3.3.1.1 Antirestenotic Drug-Eluting Stents 
			1.3.3.1.2 Drug Delivery Techniques 
	1.3.4 Stent Coverings and Linings 

Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements 
Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs 
Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials 
Exhibit 1-4: Selected Polymeric Stent Materials 
Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents 
Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents 

2. OVERVIEW OF STENTING FOR PERIPHERAL VASCULAR APPLICATIONS

2.1 Cardiovascular Disease 
	2.1.1 Incidence and Prevalence 
2.2 Peripheral Vascular Disease 
	2.2.1 Peripheral Artery Disease 
		2.2.1.1 Carotid Artery Disease 
		2.2.1.2 Lower Extremity Peripheral Artery Disease 
		2.2.1.3 Mesenteric Artery Disease 
		2.2.1.4 Renal Artery Stenosis 
		2.2.1.5 Aneurysm 
			2.2.1.5.1 Abdominal Aortic Aneurysm 
		2.2.1.6 Other Types of Peripheral Artery Disease 
	2.2.2 Peripheral Venous Disorders 
		2.2.2.1 Chronic Venous Insufficiency 
		2.2.2.2 Thrombophlebitis 
		2.2.2.3 Varicose Veins 
	2.2.3 Causes 
		2.2.3.1 Atherosclerosis 
			2.2.3.1.1 Incidence and Prevalence 
			2.2.3.1.2 Treatment 
		2.2.3.2 Hypertension 
			2.2.3.2.1 Incidence and Prevalence 
			2.2.3.2.2 Treatment 
		2.2.3.3 Diabetes 
			2.2.3.3.1 Type 1 Diabetes 
			2.2.3.3.2 Type 2 Diabetes 
			2.2.3.3.3 Macrovascular Disease 
			2.2.3.3.4 Hyperglycemia and Atherosclerosis 
			2.2.3.3.5 Hyperinsulinemia and Atherosclerosis 
			2.2.3.3.6 Incidence and Prevalence 
			2.2.3.3.7 Treatment 
	2.2.4 Surgical Intervention 
		2.2.4.1 Ablative Laser-Assisted Angioplasty 
		2.2.4.2 Bypass Grafting 
		2.2.4.3 Catheter-Based Thrombolysis and Mechanical Thrombectomy 
		2.2.4.4 Cryo-Balloon Angioplasty 
		2.2.4.5 Endarterectomy 
		2.2.4.6 Percutaneous Transluminal Angioplasty 
		2.2.4.7 Peripheral Atherectomy 
		2.2.4.8 Vascular Brachytherapy 
		2.2.4.9 Intravascular Stenting 
			2.2.4.9.1 Drug-Eluting Stents 

Exhibit 2-1: 2008, Europe, Cardiovascular Disease-Related Deaths, by Country 
Exhibit 2-2: The Peripheral Arteries 
Exhibit 2-3: Arteries of the Head and Neck 
Exhibit 2-4: Arteries of the Lower Body 
Exhibit 2-5: Classification of Abdominal Aortic Aneurysms 
Exhibit 2-6: 2008, Europe, Deaths Due to Ischemic Heart Disease, by Age 
Exhibit 2-7: 2004, Systolic Blood Pressure Levels in Selected European Countries 
Exhibit 2-8: 2010, Europe, Diabetes Prevalence, by Country 

3. EUROPEAN PERIPHERAL VASCULAR STENTS MARKET

3.1 Iliac Artery Stents 
	3.1.1 Products and Technologies 
	3.1.2 Market Analysis 
	3.1.3 Competitive Analysis 
3.2 Femoropopliteal Stents 
	3.2.1 Products and Technologies 
	3.2.2 Market Analysis 
	3.2.3 Competitive Analysis 
3.3 Transjugular Intrahepatic Portosystemic Shunts 
	3.3.1 Products and Technologies 
	3.3.2 Market Analysis 
	3.3.3 Competitive Analysis 
3.4 Renal Artery Stents 
	3.4.1 Products and Technologies 
	3.4.2 Market Analysis 
	3.4.3 Competitive Analysis 
3.5 Endovascular Abdominal Aortic Aneurysm Repair Stent-Grafts 
	3.5.1 Products and Technologies 
	3.5.2 Market Analysis 
	3.5.3 Competitive Analysis 
3.6 Carotid Artery Stents 
	3.6.1 Products and Technologies 
	3.6.2 Market Analysis 
	3.6.3 Competitive Analysis 
3.7 Combined Market Analysis 
	3.7.1 Market Drivers 
	3.7.2 Market Limiters 
	3.7.3 Market Forecast 

Exhibit 3-1: 2011, Selected Iliac Artery Stents 
Exhibit 3-2: Europe, Iliac Artery Stenting, Procedure Volumes Forecast, 2010-2014 
Exhibit 3-3: Europe, Iliac Artery Stents, Market Forecast, 2010-2014 
Exhibit 3-4: 2010, Europe, Iliac Artery Stents Market, Share by Supplier 
Exhibit 3-5: 2011, Selected Femoropopliteal Stents 
Exhibit 3-6: Europe, Femoropopliteal Stenting, Procedure Volumes Forecast, 2010-2014 
Exhibit 3-7: Europe, Femoropopliteal Stents, Market Forecast, 2010-2014 
Exhibit 3-8: 2010, Europe, Femoropopliteal Stents Market, Share by Supplier 
Exhibit 3-9: 2011, Selected Transjugular Intrahepatic Portosystemic Shunts 
Exhibit 3-10: Europe, Transjugular Intrahepatic Portosystemic Shunting, Procedure Volumes Forecast, 2010-2014 
Exhibit 3-11: Europe, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2010-2014 
Exhibit 3-12: 2010, Europe, Transjugular Intrahepatic Portosystemic Shunts Market, Share by Supplier 
Exhibit 3-13: 2011, Selected Renal Artery Stents 3-32
Exhibit 3-14: Europe, Renal Artery Stenting, Procedure Volumes Forecast, 2010-2014 
Exhibit 3-15: Europe, Renal Artery Stents, Market Forecast, 2010-2014 
Exhibit 3-16: 2010, Europe, Renal Artery Stents Market, Share by Supplier 
Exhibit 3-17: 2011, Selected Endovascular Abdominal Aortic Aneurysm  Stent-Grafts 
Exhibit 3-18: Europe, Endovascular Abdominal Aortic Aneurysm Stent-Graft Repair, Procedure Volumes Forecast, 2010-2014 
Exhibit 3-19: Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2010-2014 
Exhibit 3-20: 2010, Europe, Endovascular Abdominal Aortic Aneurysm  Stent-Grafts Market, Share by Supplier 
Exhibit 3-21: 2011, Selected Carotid Artery Stents 
Exhibit 3-22: Europe, Carotid Artery Stenting, Procedure Volumes Forecast, 2010-2014 
Exhibit 3-23: Europe, Carotid Artery Stents, Market Forecast, 2010-2014 
Exhibit 3-24: 2010, Europe, Carotid Artery Stents Market, Share by Supplier 
Exhibit 3-25: Europe, Peripheral Vascular Stents, Combined Market Forecast, 2010-2014 

4. COMPANY PROFILES

4.1 Abbott Laboratories 
4.2 C.R. Bard, Inc. 
4.3 Boston Scientific Corporation 
4.4 Cook Group, Inc. 
4.5 ev3, Inc./Covidien, Inc. 
4.6 W.L. Gore & Associates, Inc. 
4.7 Johnson & Johnson 
4.8 Medtronic, Inc.


COMPANIES COVERED:

  1. Abbott Laboratories
  2. AngioDynamics, Inc.
  3. Atrium Medical, Inc.
  4. C.R. Bard, Inc.
  5. Bard Peripheral Vascular/ C.R. Bard, Inc.
  6. BIOTRONIK SE Co. & KG
  7. Boston Scientific Corporation
  8. Cook Medical/Cook Group, Inc.
  9. Cook Group, Inc.
  10. Cordis Corporation/ Johnson & Johnson
  11. Covidien PLC
  12. ELLA-CS SRO
  13. Endologix, Inc.
  14. ev3, Inc./Covidien PLC
  15. W.L. Gore & Associates, Inc.
  16. Johnson & Johnson
  17. LeMaitre Vascular, Inc.
  18. Lombard Medical Technologies PLC
  19. Medtronic, Inc.
  20. Minvasys SA
  21. OptiMed Medizinische Instrumente GmbH
  22. Terumo Corporation
  23. Vascutek/Terumo Corporation
Contact Us

Need help finding medtech research? Let us help you!